Explore the 7,410 U.S. Patent Applications published on the 29th week of 2024, including 63 applications that subsequently received a Patent Grant.
BEVERAGE AND FOOD PRODUCTION
A new method has been developed for making a unique beer-like drink. This process not only creates a tasty beverage but also helps reduce food waste by using leftover pasta. It involves turning milled dry grain flour into dough, cooking it with steam, and then fermenting it with yeast and water. The approach is designed to be more efficient and environmentally friendly, addressing concerns about energy use in production. Overall, this innovation combines food and drink production in a way that benefits both industries.
Published: 2024-07-18 Assignee: PURDUE RESEARCH FOUNDATION.NANOCONSTRUCTS AND NANOPARTICLE-MEDIATED DELIVERY OF IMMUNOGENIC CELL DEATH INDUCERS FOR ENHANCING CANCER IMMUNOTHERAPY
Nanoconstructs are tiny particles designed to help treat cancer by delivering special drugs that can trigger the immune system. These particles are coated with a substance called ATP, which helps boost the body's immune response. They contain therapeutic agents that induce a type of cell death that is beneficial for fighting cancer. The goal is to improve cancer immunotherapy by using these advanced delivery systems. This approach aims to make treatments more effective by working with the body's natural defenses against cancer.
Published: 2024-07-18 Assignee: APPLE INC..Wide Field of View Five Element Lens System
A new lens system is designed for small cameras, like those in smartphones. It has five lens elements and can capture wide images with a field of view greater than 82 degrees. The system also has a low F-number of 2.4 or less, allowing for better light capture and image quality. Special adjustments are made to reduce common visual problems that can occur in images. Overall, this lens aims to improve the performance of compact cameras while keeping them small and lightweight.
Published: 2024-07-18 Assignee: INTEL CORPORATION.IMMUTABLE WATERMARKING FOR AUTHENTICATING AND VERIFYING AI-GENERATED OUTPUT
A system has been developed to ensure that content created by artificial intelligence (AI) is authentic and can be trusted. It works by receiving two pieces of content from different devices, where one piece comes from a machine learning model. The system extracts a unique identifier from the digital signature of this content. It then checks this identifier against a shared registry to confirm the model's identity. If the identifier is verified, the content is marked as authentic and can be used confidently.
Published: 2024-07-18SARS-COV-2 SPIKE PROTEIN ANTIBODIES
Antibodies that specifically target the spike protein of the SARS-CoV-2 virus have been developed. These antibodies can be used in treatments, prevention, and detection of COVID-19. The spike protein is crucial for the virus to enter human cells, making these antibodies important for fighting the infection. COVID-19, caused by SARS-CoV-2, has led to millions of cases and deaths worldwide since its emergence in late 2019. Currently, there are no definitive treatments for COVID-19, but research is ongoing to find effective solutions.
Published: 2024-07-18CHIMERIC ANTIGEN RECEPTOR-MODIFIED GRANULOCYTE-MACROPHAGE PROGENITORS FOR CANCER IMMUNOTHERAPY
Granulocyte-macrophage progenitors (GMPs) are important immune cells that help protect the body from infections and diseases, including cancer. Researchers have developed a method to genetically modify these GMPs so they can produce a special receptor called a chimeric antigen receptor (CAR). This modification allows the GMPs to better target and fight cancer cells. The modified GMPs can be grown in large numbers while still functioning properly, which is crucial for their use in treatments. Tests showed that these engineered GMPs successfully helped prevent infections in mice with weakened immune systems.
Published: 2024-07-18IN-SITU CRYO-IMMUNE ENGINEERING FOR CANCER IMMUNOTHERAPY
Cancer immunotherapy helps the immune system fight tumors, but it often struggles due to a suppressive environment around the tumors. The in-situ cryo-immune engineering (ICIE) method changes this environment from "cold" to "hot," making it easier for the immune system to attack. This treatment uses cold-responsive nanoparticles that target cancer cells and cause a "frostbite" effect, releasing anticancer drugs and specific RNA into the cancer cells. As a result, it triggers a strong immune response, leading to the activation of important immune cells like CD8+ cytotoxic T cells. Overall, ICIE offers a promising way to enhance the immune system's ability to fight cancer and prevent its spread.
Published: 2024-07-18 Assignee: Sony Group Corporation.INFORMATION PROCESSING DEVICE AND INFORMATION PROCESSING METHOD FOR ARTIFICIAL SPEECH GENERATION
An information processing device can create artificial speech that sounds more natural and emotional. It does this by analyzing existing speech data to identify emotional cues and their timing. The device also extracts text from the speech data to understand what is being said. By combining the text with the emotional indicators, it generates new speech that reflects both the content and the intended emotions. This technology aims to enhance artificial speech generation, making it more expressive and relatable.
Published: 2024-07-18 Assignee: Adobe Inc..REAL TIME STREAMABLE PAGE GENERATION FROM A DIGITAL DOCUMENT
A system creates pages from a digital document that can be streamed in real time. Each page has special information at the start, called metadata, which helps devices know how to display the page correctly. When a device, like a printer, gets these pages, it can show them as separate parts or full pages. This method allows for better handling of large digital documents without losing quality. Overall, it makes it easier for different devices to work with digital documents efficiently.
Published: 2024-07-18SARS-COV-2 MULTI-EPITOPE VACCINES
Multi-epitope vaccines are designed to fight the SARS-COV-2 virus, which causes COVID-19. These vaccines include multiple parts of the virus that are less likely to change over time, making them more effective against different variants. They aim to trigger an immune response in a wide range of people by including elements that work with various human immune system markers. This approach is important because traditional vaccines often focus on one part of the virus, which can mutate and become less effective. By using a broader strategy, these vaccines hope to provide better protection for more individuals.